Thermo Fisher Scientific said earlier this month that it conducted a restructuring in the first six months of 2024 that included headcount reductions and facility consolidations to streamline operations. According to the company’s most recent quarterly filing with the US Securities and Exchange Commission, the measures affected approximately 1 percent of its workforce. ~ Source: Genome Web
read more >Industry Reporting – 10x Genomics
August 8, 2024: Industry budgets are impacting 10x instrument placements.
“Our customers are under budget pressure, which has most acutely resulted in cuts to capital expenditures budgets and elongated purchase cycles, impacting our instrument revenue this quarter,” 10x CEO and Cofounder Serge Saxonov said on a conference call following the release of the results. “We believe these macro factors and…
read more >2022 Flow Cytometry Dashboard Series 2 – NA & EU
Flow cytometry is a powerful method available to scientists studying Immunology, cell biology, cancer, infectious disease, and many other areas of research to investigate processes such as cell function, cell types, target identification, protein function and cellular interactions. As life science suppliers continue to improve products and services in the flow cytometry market, flow cytometry experiment kits and reagents…
read more >2022 Protein Electrophoresis & Western Analysis Dashboard Series 5 – NA & EU
Protein electrophoresis is a commonly used technique to separate proteins and is often followed by in-gel staining and/or western analysis to detect the proteins of interest. With a wide variety of applications in proteomics, ranging from protein characterization to protein quantification and applications in other areas such as clinical diagnostics and verification of in vivo and in vitro protein…
read more >2021 Nucleic Acid Amplification Dashboard Series 5 – NA & EU
Nucleic acid amplification (NAA) is one of the most commonly performed molecular biology techniques and is a necessary precursor to a range of methods from gene cloning and site-directed mutagenesis to the quantitative analysis of gene expression. As life science suppliers continue to improve products and services in the nucleic acid amplification market, nucleic acid amplification kits and reagents…
read more >2020 NGS Library Preparation Dashboard Series 1 – NA & EU
Next generation sequencing (NGS) library preparation is a crucial step in the NGS workflow. Product evolution in this area has been swift – from original laborious, multi-day protocols requiring reagents from several suppliers, to complete kits optimized for low input, challenging sample types and automation-ready formats. Powerful and continually evolving methods are currently employed by scientists in basic and…
read more >Updated Pulse Report – Impact of COVID-19 Pandemic on Research in the USA and Europe
To keep the global research community and research product suppliers informed on the continuing impact of the COVID-19 pandemic on research efforts Percepta fielded the first COVID-19 Impact survey on April 3, 2020. This survey was re-fielded, with the addition of several questions, on May 1, 2020 and once more on June 1, 2020.
read more >2020 CRISPR Gene/Genome Editing Dashboard Series 1 – NA & EU
CRISPR technology is a simple yet powerful tool for editing genomes. It allows researchers to easily alter DNA sequences and modify gene function. Its many potential applications include correcting genetic defects, treating and preventing the spread of diseases and improving crops. As life science suppliers continue to improve products and services the CRISPR gene/genome editing market, represents a significant…
read more >Updated Pulse Report – Impact of COVID-19 Pandemic on Research in the USA and Europe
The first version of this Pulse Report was published in early April 2020. As the COVID-19 pandemic continues to take its toll on research programs across academia and pharma/biotech globally we are providing this updated complimentary report from Percepta has been provided to help you stay informed on the pandemic’s current impact on laboratory closures, funding, headcount, project changes,…
read more >New Complimentary Report from Percepta – Impact of COVID-19 Pandemic on Research in the USA and Europe
As the COVID-19 pandemic takes its toll on research programs
across academia and pharma/biotech we are in turn interested to better
understand the current research landscape and how we can best support it.
On April 3, 2020 we fielded a brief survey to the Percepta panel of life scientists. We received 1,015 completed surveys from around the globe. Key findings from the…
read more >